These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3691914)

  • 41. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
    Ghonemy S; Alarawi A; Bessar H
    J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial.
    Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K
    Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia.
    Gupta AK; Charrette A
    Skinmed; 2015; 13(3):185-9. PubMed ID: 26380504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.
    Rietschel RL; Duncan SH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):677-85. PubMed ID: 3549802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
    Kuan YZ; Chen SY; Chen MJ; Wang CN; Chan HL
    Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):96-103. PubMed ID: 2224611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical minoxidil in extensive alopecia areata, including 3-year follow-up.
    Price VH
    Dermatologica; 1987; 175 Suppl 2():36-41. PubMed ID: 3691913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical minoxidil in the treatment of alopecia areata.
    Fenton DA; Wilkinson JD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1015-7. PubMed ID: 6412929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical treatments for balding in men.
    Scow DT; Nolte RS; Shaughnessy AF
    Am Fam Physician; 1999 Apr; 59(8):2189-94, 2196. PubMed ID: 10221304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
    Fiedler-Weiss VC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial.
    Kanti V; Hillmann K; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1183-9. PubMed ID: 26387973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
    Olsen EA; Weiner MS
    J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.